Tagged as: prescription drug prices

Vizient Looks to Biosimilars to Help Contain COVID-19 Drug Price Inflation

Last week, Vizient, a healthcare performance improvement company, released its Summer 2020 Drug Price Forecast.  In the forecast, Vizient reported on the role of COVID-19 in changing healthcare priorities and affecting spending.  Particularly, it advised its member health care groups to hedge against drug price inflation, which it estimated will…

Read More

Judge Vacates Federal Regulation Mandating Disclosure of Drug Prices in TV Advertisements

In May, the U.S. Department of Health and Human Services (“HHS”) finalized a new regulation requiring pharmaceutical companies to disclose the list price of a drug in any television advertisements.  This regulation, titled “Medicare and Medicaid Programs; Regulation To Require Drug Pricing Transparency” (also known as the Wholesale Acquisition Cost,…

Read More

Prescription Drug Prices Continue to Rise Despite Generics and Biosimilars

A recent analysis reveals that prescription drug prices continue to increase — even for drugs with FDA-approved therapeutic equivalents or biosimilar products. Dr. Nathan Wineinger evaluated the change in prescription drug prices over a 6-year period for the 49 top-selling brand-name medications in the United States. The price of 48…

Read More